Human immunodeficiency virus infection and acute deep vein thromboses

Clinical and Applied Thrombosis/Hemostasis

Volumn 14, Issue 3, 2008, Pages 352-355

  Louw, Susan ^a,d   Jacobson, Barry F ^a,b   Büller, Harry ^c  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

Deep vein thrombosis; Human immunodeficiency virus; Hypercoagulable

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SOUTH AFRICA; STATISTICAL SIGNIFICANCE;

ADULT; CASE-CONTROL STUDIES; FEMALE; HIV INFECTIONS; HIV SEROPREVALENCE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SOUTH AFRICA; VENOUS THROMBOSIS;

EID: 45749083390     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/1076029607304411     Document Type: Article

References (12)

1. Dorrington RE How many people are currently infected with HIV in South Africa ? S Afr Med J. 2002 ; 92: 196-197.
2. The South African Aids Conference, Durban. 2003.
3. South African National HIV Prevalence, HIV Incidence, Behaviour and Communication Survey. Commissioned by the Nelson Mandela Foundation. 2005.
4. Saif MW, Greenberg B. HIV and thrombosis: a review. AIDS Patient Care STDS. 2001 ; 15: 15-24.
5. Klein SK, Slim EJ, de Kruif MD, et al. Is chronic HIV infection associated with venous thrombotic disease? A systematic review. Neth J Med. 2005 ; 63: 129-136.
6. Joint United Nations Programme on HIV/AIDS (UNAIDS): report on global AIDS epidemic. 2004.
7. Koppel K., Bratt G., Schulman S., Bylund H., Sandstrom E. Hypofibrinolytic state in HIV-I-infected patients treated with protease inhibitor-containing highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2002 ; 29: 441-449.
8. Shen YM, Frenkel EP Thrombosis and a hypercoagulable state in HIV-infected patients. Clin Appl Thromb Hemost. 2004 ; 10: 277-280.
9. Hassoun A., Al-Kadhimi Z., Cervia J. HIV infection and antiphospholipid antibody: literature review and link to the antiphospholipid syndrome. AIDS Patient Care STDS. 2004 ; 18: 333-340.
10. Keller TT, Mairuhu AT, de Kruif MD, et al. Infection and endothelial cells. Cardiovasc Res. 2003 ; 60: 40-48.
11. Grau AJ, Lichy C. Stroke and the CD40-CD40 ligand system: at the hinge between inflammation and thrombosis. Stroke. 2003 ; 34: 1417.
12. Wolf K., Tsakiris DA, Weber R., Erb P., Battegay M. ; Swiss HIV Cohort Study. Antiretroviral therapy reduces markers of endothelial and coagulation activation in patients infected with human immunodeficiency virus type I. J Infect Dis. 2002 ; 185: 456-462.